News
Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right - EMERYVILLE, Calif., Aug. 11, 2025 ...
Explore XOMA's shift to M&A with CVRs, recent LVTX & HLVX deals, and their potential impact. Learn why analysts maintain a ...
NasdaqGM:XOMA 1 Year Share Price vs Fair Value Explore XOMA Royalty's Fair Values from the Community and select ...
Turnstone Stockholders Received $0.34 Per Share in Cash Plus Contingent Value Right - EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) ("XOMA Royalty" or ...
Detailed price information for Xoma Royalty Corporation (XOMA-Q) from The Globe and Mail including charting and trades.
BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...
The Ademi Firm is investigating HilleVax (NASDAQ: HLVX) for possible breaches of fiduciary duty and other violations of law in its transaction with XOMA Royalty Corporation.
5d
Zacks Investment Research on MSNPTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates
PTC Therapeutics (PTCT) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $1.16 per share a year ago. These figures ...
6d
Zacks Investment Research on MSNNovavax (NVAX) Q2 Earnings and Revenues Top Estimates
Novavax (NVAX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to earnings of $0.99 per share a year ago. These ...
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of ...
SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results